Recardio
PrivateLast Round
Series A
Nov 11, 2015
Total Funding Raised
$3M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Recardio operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series A round in November 2015.
Recardio is a biotechnology company that develops small molecule therapeutics for cardiovascular diseases that promote natural regenerative capacity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Recardio Comparables
Compare Recardio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Serca Pharmaceuticals | 77% | |
| CellProthera | 77% | |
| Prolifagen | 77% |
For institutional investors. Book with your work email.
Recardio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased by 200%, from 0 to 2.
- Jan 20, 2026
Monthly visitors increased 2024% MoM, from 41 to 871.
For institutional investors. Book with your work email.
Recardio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Recardio's valuation, stock price, and market status.
Is Recardio a public or private company?
Recardio is a private company.
What is the current stock price of Recardio?
Recardio is a private company, so its shares have no public market price. Caplight tracks Recardio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Recardio worth (valuation)?
Valuation information for Recardio is not publicly available.
Can I buy Recardio stock?
Recardio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Recardio's last funding round?
Recardio's most recent funding round was Series A on November 11, 2015.
Who are the main investors in Recardio?
Investor information for Recardio is not publicly disclosed.
Will Recardio IPO soon?
No public IPO plans have been announced for Recardio.
How can I track Recardio secondary market activity?
Caplight tracks bids, offers, and trades in Recardio's shares on secondary markets.